Thymus changes in anti-MuSK-positive and -negative myasthenia gravis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read the article by Lauriola et al.1 with great interest. The investigators studied thymic morphological changes in 12 anti-acetylcholine receptor antibodies (AChR)-negative and anti-muscle specific receptor tyrosine kinase antibodies (MuSK)-positive, in 20 AChR- and MuSK-negative, and in 30 AChR-positive patients. They found no or minimal abnormalities in MuSK-positive patients, whereas hyperplastic changes were seen in 35% of MuSK- and AChR-negative patients and in 67% of the AChR-positive cases. The authors suggest that there is no role of intrathymic disease in MuSK-positive MG pathogenesis.
We have a 30-year-old female patient with seronegative thymomatous MG with positive MuSK antibodies. In October 2001, she had diplopia, ptosis, and dysphagia. She responded well to pyridostigmine and prednisolone combination, and underwent a thymectomy. Thymic histology disclosed a …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Review
Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravisErnestina Santos, Ana Martins Silva, Philipp Stroebel et al.Neurology: Clinical Practice, November 07, 2018 -
Five New Things
Myasthenia gravisFive new thingsJeffrey M. Statland, Emma Ciafaloni et al.Neurology: Clinical Practice, April 15, 2013 -
Editorials
What’s in the serum of seronegative MG and LEMS?MuSK et al.Angela Abicht, Hanns Lochmüller et al.Neurology, December 10, 2002 -
Views & Reviews
International consensus guidance for management of myasthenia gravisExecutive summaryDonald B. Sanders, Gil I. Wolfe, Michael Benatar et al.Neurology, June 29, 2016